World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
104
Citations
51983
World Ranking
6938
National Ranking
3655

Overview

Ruben A. Mesa is affiliated with The University of Texas Health Science Center at San Antonio in the United States. Their research primarily focuses on areas within medicine, with a notable emphasis on genetics, hematology, molecular biology, rheumatology, and oncology as subfields of study.

The scientist's work covers a range of topics, notably:

  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Chronic Myeloid Leukemia Treatments
  • Acute Myeloid Leukemia Research
  • Eosinophilic Disorders and Syndromes
  • Kruppel-like factors research
  • Hemoglobinopathies and Related Disorders
  • Multiple Myeloma Research and Treatments

Ruben A. Mesa has contributed to several recent publications, including:

  • Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study, 2020, The Lancet
  • Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium, 2021, Annals of Oncology
  • Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer, 2021, Cancer Cell
  • The Impact of COVID-19 on Cancer Screening: Challenges and Opportunities, 2020, JMIR Cancer
  • Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study, 2023, The Lancet

The scientist frequently collaborates with several researchers, namely Claire Harrison, Srđan Verstovšek, Jean-Jacques Kiladjian, Alessandro M. Vannucchi, and Stephen T. Oh. These collaborative relationships are reflected in multiple co-authored publications.

Ruben A. Mesa's work is prominently published in venues such as:

  • Blood
  • Clinical Lymphoma Myeloma & Leukemia
  • HemaSphere
  • Journal of Clinical Oncology
  • Blood Advances

Their publication record indicates a strong focus on hematology and oncology-related research, with extensive contributions to myeloproliferative neoplasms and leukemia treatments. The integration of COVID-19-related cancer research within their recent works illustrates an engagement with emergent clinical challenges.

Best Publications

  • Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.

    Ross L. Levine;Ross L. Levine;Martha Wadleigh;Jan Cools;Benjamin L. Ebert;Benjamin L. Ebert

  • A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis

    Srdan Verstovsek;Ruben A. Mesa;Jason Gotlib;Richard S. Levy

  • Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.

    Nicole M. Kuderer;Toni K. Choueiri;Dimpy P. Shah;Yu Shyr

  • Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis

    Srdan Verstovsek;Hagop Kantarjian;Ruben A. Mesa;Animesh D. Pardanani

  • New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment.

    Francisco Cervantes;Brigitte Dupriez;Arturo Pereira;Francesco Passamonti

  • MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients

    Animesh D. Pardanani;Ross L. Levine;Terra Lasho;Yana Pikman

  • Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations From European LeukemiaNet

    Tiziano Barbui;Giovanni Barosi;Gunnar Birgegard;Francisco Cervantes

  • Ruxolitinib versus Standard Therapy for the Treatment of Polycythemia Vera

    Alessandro M. Vannucchi;Jean Jacques Kiladjian;Martin Griesshammer;Tamas Masszi

  • Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel.

    Ayalew Tefferi;Juergen Thiele;Attilio Orazi;Hans Michael Kvasnicka

  • TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis

    A. Tefferi;A. Pardanani;K. H. Lim;K. H. Lim;O. Abdel-Wahab

  • Philadelphia chromosome-negative classical myeloproliferative neoplasms: Revised management recommendations from European LeukemiaNet

    Tiziano Barbui;Ayalew Tefferi;Alessandro M. Vannucchi;Francesco Passamonti

  • Leukemic transformation in myelofibrosis with myeloid metaplasia: a single-institution experience with 91 cases

    Ruben A. Mesa;Chin Yang Li;Rhett P. Ketterling;Georgene S. Schroeder

  • The burden of fatigue and quality of life in myeloproliferative disorders (MPDs): an international Internet-based survey of 1179 MPD patients.

    Ruben A. Mesa;Joyce Niblack;Martha Wadleigh;Srdan Verstovsek

  • Myeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNs

    Robyn M. Emanuel;Amylou C. Dueck;Holly L. Geyer;Jean Jacques Kiladjian

  • Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosis: A Randomized Clinical Trial.

    Animesh Pardanani;Claire Harrison;Jorge E. Cortes;Francisco Cervantes

  • Population-based incidence and survival figures in essential thrombocythemia and agnogenic myeloid metaplasia: an Olmsted County Study, 1976-1995.

    Ruben A. Mesa;Murray N. Silverstein;Steven J. Jacobsen;Peter C. Wollan

  • Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the International Working Group for Myelofibrosis Research and Treatment.

    G. Barosi;R. A. Mesa;J. Thiele;F. Cervantes

  • Revised response criteria for myelofibrosis: International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) and European LeukemiaNet (ELN) consensus report

    Ayalew Tefferi;Francisco Cervantes;Ruben Mesa;Francesco Passamonti

  • Primary myelofibrosis (PMF), post polycythemia vera myelofibrosis (post-PV MF), post essential thrombocythemia myelofibrosis (post-ET MF), blast phase PMF (PMF-BP): Consensus on terminology by the international working group for myelofibrosis research and treatment (IWG-MRT).

    Ruben A. Mesa;Srdan Verstovsek;Francisco Cervantes;Giovanni Barosi

  • The Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF): international prospective validation and reliability trial in 402 patients

    Robyn Scherber;Amylou C. Dueck;Peter Johansson;Tiziano Barbui

Frequent Co-Authors

Srdan Verstovsek
Srdan Verstovsek The University of Texas MD Anderson Cancer Center
Ayalew Tefferi
Ayalew Tefferi Mayo Clinic
Claire N. Harrison
Claire N. Harrison Guy's and St Thomas' NHS Foundation Trust
Amylou C. Dueck
Amylou C. Dueck Mayo Clinic
Alessandro M. Vannucchi
Alessandro M. Vannucchi University of Florence
Francesco Passamonti
Francesco Passamonti University of Milan
Jason Gotlib
Jason Gotlib Stanford University
Francisco Cervantes
Francisco Cervantes University of Barcelona
Vikas Gupta
Vikas Gupta Princess Margaret Cancer Centre

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Aspiring medical professionals have more online opportunities than ever before. If you’re considering a career in healthcare but aren't set on becoming a doctor, there are flexible alternatives that allow you to study and work at the same time.

For those interested in leadership, healthcare administration degrees offer training in organizational management and health policy. Many are now available online, making it easier for working professionals to advance their careers.

Nurses seeking to upskill can explore bridge programs, such as the asn to np pathway. These programs support registered nurses who want to become nurse practitioners and often combine academic coursework with practical experience.

Nutrition is another growing field. Earning an online bachelor's degree in nutrition can open doors to roles in public health, counseling, and wellness coaching, all through fully online coursework.

For those ready to take on senior healthcare roles, cahme accredited online healthcare administration programs provide rigorous, industry-respected training for positions in hospital management, healthcare consulting, and beyond.

Best Scientists Citing Ruben A. Mesa

Trending Scientists

Recently Published Articles